Altimmune, Inc. ALT Cash Flow

Altimmune, inc. (ALT)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
-3,885	-4,096	-10,939	-3,386	-2,097	-24,507	-2,351	-9,138	-3,173	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-4,578	77,801	119,282	-2,003	-1,226	-1,238	-1,324	-2,340	1,463	-2,629	-4,628	-439	-2,258	-4,424	-3,945	-1,236	-2,111	-1,269	-213	-756	-2,679
Adjustments to reconcile net loss to net cash used in operating activities:
Change in value of contingent consideration for acquired in-process research and development
1,750	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment charges
-	-	-	-	-	24,450	0	0	490	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
214	278	287	289	407	68	95	252	356	306	453	339	345	343	1,506	207	181	186	93	133	199	482	280	363	528	405	304	324	328	394	439	512	548
Depreciation
59	58	59	60	61	72	68	52	25	22	23	24	12	33	80	-7	37	32	35	36	37	36	37	36	39	43	44	41	52	-	-	-	-
Amortization
13	11	28	14	92	38	15	14	14	14	14	13	12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized losses (gains) on foreign currency exchange
-24	2	-21	-21	46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt discount accretion
-	-	-	-	-	-	-	-	-	0	0	59	38	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of premium and discount on short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	10	-	18	22	26	30	34	38	32	41	40	40	0
Gain from disposal of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	7	0	0	0	5	0	3	0	0	0	0	0	66
Changes in fair value of warrant liability
-	-	-	-	-	4	-806	5,228	-1,547	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in fair value of embedded derivative
-	-	-	-	-	0	185	4	-7	-	-	-	-	-	-	-	39	-277	359	-120	338	44	-560	782	242	736	-628	352	-905	249	508	823	-991
Changes in operating assets and liabilities:
Accounts receivable
973	8	-1,617	-276	-555	914	-307	-900	-51	554	-670	2,193	-129	-363	359	135	-341	511	-387	-5,586	5,863	110	0	0	-1,427	1,427	-1,540	-325	-566	826	-1,838	2,298	-3,278
Prepaid expenses and other current assets
214	46	-292	169	-55	90	-110	-233	-246	198	-437	638	-50	-44	372	-326	282	-14	-117	-126	253	29	-302	99	178	31	42	-316	-39	190	-308	-111	-137
Accounts payable
911	-31	-220	255	-358	222	-94	-260	376	-350	-645	-3,194	1,566	311	-29	477	-354	214	97	-329	146	109	-155	-34	-656	18	-1,880	1,700	-407	-149	-216	652	-35
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-733	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued restructuring expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-196	-	-	-	1,938	0	0	0	0	-	-	-	-	-	-	-	-
Accrued expenses and other current liabilities
1,175	1,499	-1,031	-394	-699	-1,678	534	443	716	-	-	-	-	309	919	-906	466	-204	-497	417	230	-1,315	1,064	-563	-1,274	569	570	-1,316	950	-873	47	276	131
Deferred revenue
-18	36	-17	-14	17	-4	-17	-17	20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued income taxes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-17	-17	20	-	-	-	-	-	-	-	-	-56	56	-62	-279	-130	-36	-366	-507	1,334	28	-0	-495
Deferred rent
-	-	-	-	-	-	-	-	-	-32	1	4	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease obligation
44	41	44	45	44	-	-	-715	-49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	303	303	-130	195	296	-6	-313	-1,032	-549	586	-2,081	-19	-400	432	-1,103	510	1,254
Tax refund receivable
3,360	-339	-111	13	57	-237	-2,595	-2,938	694	1,263	1,417	522	203	-	-	87	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76	85
Deferred tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	15	15	11	19	13	25	-6	29	11	28	11	9	6	22	16	150
Deferred taxes
-	-	-	-	-	-	1,539	1,009	497	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of available-for-sale investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-4,347	-2,002	-2,426	-3,060	-2,112	-5,155	-1,022	348	-3,558	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-533	-2,294	-	-676	-495	260	-	1,734	-2,703	791
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sales and maturities of short-term investments
13,700	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of short-term investments
7,099	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-3,343	82,863	121,611	-1,611	-1,355	-1,828	-1,326	2,653	-2,713	-	-	-	-	-	-	-	-	-	-	-	-
Refund of cash held in escrow
-	-	-	-	-	-	-	-	-	-	0	0	200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of property and equipment
18	0	0	0	1	7	156	159	652	22	5	44	39	0	17	12	0	18	12	20	35	0	13	42	37	0	13	45	25	0	0	0	0
Proceeds from sale of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	7	0	0	0	8	0	3	0	0	0	0	0	67
Cash paid for internally developed patents
19	2	9	12	3	1	11	12	14	6	17	13	17	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
6,563	-52	-28,216	-12	-4	-8	-153	-171	-667	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-42	-29	-	-10	-45	-25	-	0	0	67
CASH FLOWS FROM FINANCING ACTIVITIES:
Net cash (used in) provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	143	-0	-66,817	-59	-0	-18	-12	-20	-27	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of convertible notes, net of issuance costs
-	-	-	-	-	-	-	-	-	0	0	0	3,018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from stock subscriptions
-	-	-	-	-	-	-	-	-	-	-	-	35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29	567	292	84	2,800	10,065	2,556	2,719	-50	2,258	3,756	53	0	0	38	0
Proceeds from issuance of common units, net of issuance costs
-	0	0	0	12,668	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock from Employee Stock Purchase Plan
56	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-250	-249	-249	-249	-249	-249	-249	-249	-249	-249	0	-	-	-	-
Proceeds from issuance of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,500
Net repayment of revolving credit agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-1,091	1,091	-1,168	-161	-1	122	1,208	-857	857
Deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	112	0	0	-3	220
Controlled equity offering issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in restricted cash requirements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	100
Proceeds from exercises of warrants
39	-	-	0	30	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	4	18	0	16	0	0	-	-	-	23	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
96	44	-55	-156	12,699	31,518	4,412	-3,459	18	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,306	1,377	-	840	3,458	-60	-	1,208	-815	3,204
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	0	0	0	-	-	-	-	-	-	-	-	0	0	0	-32
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	3,054	2,028	-1,842	3,592	22	29	317	42	-165	-	-	-	-	-	-	-	-	-	-	-	-
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
-	-	-	-	-	0	0	-48	-1	-12	35	44	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents and restricted cash
2,312	-2,009	-30,699	-3,229	10,581	26,354	3,235	-3,331	-4,209	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EFFECT OF EXCHANGE RATES ON CASH
-	-	-	-	-	-	-	-	-	-	-	-	-	-3	97	-98	-1	-1	-0	12	-11	-5	-6	-0	-0	2	0	-1	-2	-1	6	-8	4
Net decrease in cash, cash equivalents, and restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-138	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,334	-1,819	-1,022	2,686	-2,918	-977	8,355	1,730	-946	-5,462	153	2,916	171	-2,024	2,949	-3,527	4,067
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
-	-	-	-	-	7	47	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	7	0	-1	1	0	0	86	6	14	22	28	34	43	49	55	61	67	74	71	70	3
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES
Accrued expense capitalized as convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	842	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock warrant issued with convertible notes, net of issuance costs
-	-	-	-	-	-	-	-	-	0	-17	0	566	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Addition of property and equipment not yet paid
-	-	-	-	-	-	-	-3	142	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Addition of intangible assets not yet paid
-	-	-	-	-	-	-	-6	12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease incentive billed but not yet received
-	-	-	-	-	-	-	-545	684	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Value of warrants issued to lender in connection with loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	69
Series B Redeemable Convertible Preferred Stock [Member]
Conversion of Series B redeemable convertible preferred stock into common stock
-	-	-	-	-	-0	535	4,036	5,218	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of Series B redeemable convertible preferred stock
-	-	-	-	-	0	47	956	1,891	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-